Literature DB >> 18393901

The complex role of pro- and anti-inflammatory cytokines in cysticercosis: immunological lessons from experimental and natural hosts.

Luis I Terrazas1.   

Abstract

Parasitic helminthes have developed complex mechanisms to evade or modulate hosts responses. Studies on cysticercosis are solid, but scarce. The most studied immunological models of cysticercosis are Taenia crassiceps infecting mice and T. solium infecting pigs. These parasites, despite being widely exposed to the host, are able to modulate the host immune system. Taenia metacestodes, much like other helminthes parasites, have developed complicated strategies in order to infect and successfully colonize their hosts. We focus here on the accumulated evidence from experimental models that have been helpful in analyzing and characterizing the host immune response to cysticercosis. Moreover, the mouse model has been used to design rationale vaccine strategies, some of them with promising results. We also discuss recent advances in understanding immune-regulation of cysticercosis. The parasite is able to manipulate the host immune system into supporting its survival by keeping a low inflammatory profile by causing the production of some cysticerci-released products that have immunomodulatory activities, as well as promoting the raise of alternatively activated macrophages. Finally, we delineate, according to recent literature, the likely pathway involved in protection and susceptibility against cysticercosis. As more aspects of the role of different immune and parasite-derived molecules are elucidated, better therapeutic targets may be identified to help treat cysticercosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393901     DOI: 10.2174/156802608783790848

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  14 in total

1.  Helminth-excreted/secreted products are recognized by multiple receptors on DCs to block the TLR response and bias Th2 polarization in a cRAF dependent pathway.

Authors:  César A Terrazas; Marcela Alcántara-Hernández; Laura Bonifaz; Luis I Terrazas; Abhay R Satoskar
Journal:  FASEB J       Date:  2013-08-01       Impact factor: 5.191

Review 2.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

3.  EXPERIMENTAL SUBCUTANEOUS CYSTICERCOSIS BY Taenia crassiceps IN BALB/c AND C57BL/6 MICE.

Authors:  Íria Márcia Pereira; Sarah Buzaim Lima; Aline de Araújo Freitas; Marina Clare Vinaud; Ruy de Souza Lino Junior
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-07-11       Impact factor: 1.846

4.  STAT6⁻/⁻ mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis.

Authors:  Bibhuti B Mishra; Uma Mahesh Gundra; Judy M Teale
Journal:  J Neuroimmunol       Date:  2010-11-03       Impact factor: 3.478

5.  In vivo albendazole treatment of Taenia crassiceps cysticerci strain WFU: proliferation, damage, and recovery.

Authors:  R Zurabian; L Aguilar-Vega; E Terrones Vargas; M E Cervera Hernández; K Willms; S Ruíz-Velasco Acosta
Journal:  Parasitol Res       Date:  2013-09-05       Impact factor: 2.289

6.  Immune-inflammatory markers in massively disseminated cysticercosis.

Authors:  Akhila Kumar Panda; Binod Kumar Pati
Journal:  BMJ Case Rep       Date:  2014-04-09

Review 7.  Corticosteroid use in neurocysticercosis.

Authors:  Theodore E Nash; Siddhartha Mahanty; Hector H Garcia
Journal:  Expert Rev Neurother       Date:  2011-08       Impact factor: 4.618

8.  Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation.

Authors:  Giuliana López-Navarrete; Espiridión Ramos-Martínez; Karina Suárez-Álvarez; Jesús Aguirre-García; Yadira Ledezma-Soto; Sonia León-Cabrera; Marco Gudiño-Zayas; Carolina Guzmán; Gabriela Gutiérrez-Reyes; Joselín Hernández-Ruíz; Ignacio Camacho-Arroyo; Guillermo Robles-Díaz; David Kershenobich; Luis I Terrazas; Galileo Escobedo
Journal:  Int J Biol Sci       Date:  2011-10-25       Impact factor: 6.580

Review 9.  A research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiases.

Authors:  Sara Lustigman; Peter Geldhof; Warwick N Grant; Mike Y Osei-Atweneboana; Banchob Sripa; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

10.  Helminth induced suppression of macrophage activation is correlated with inhibition of calcium channel activity.

Authors:  Arun Chauhan; Yuyang Sun; Biswaranjan Pani; Fredice Quenumzangbe; Jyotika Sharma; Brij B Singh; Bibhuti B Mishra
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.